Internal Medicine, Infectious Disease · Houston, TX
NPI
1285898403
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
12025 Louetta Rd Ste B
Houston, TX, 77070
Phone (281) 251-7888
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
2,856 services
Medicare patients, 2024
412
Average age 75
Drug cost, 2024
$275K
841 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brijesh Raval was code 99232 (hospital e&m - subsequent), 2,274 times for 374 patients. In total Brijesh Raval billed 2,856 services in 9 codes, and Medicare paid $200K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,274 | 374 | $62.50 | $142K |
| 99222 Hospital E&M - Initial | Facility | 263 | 250 | $104.73 | $28K |
| 99223 Hospital E&M - Initial | Facility | 134 | 116 | $137.44 | $18K |
| 99231 Hospital E&M - Subsequent | Facility | 84 | 44 | $39.33 | $3,304 |
| 99221 Hospital E&M - Initial | Facility | 42 | 41 | $66.74 | $2,803 |
| 99214 Office E&M - Established | Office | 31 | 22 | $99.41 | $3,082 |
| 99233 Hospital E&M - Subsequent | Facility | 17 | 16 | $89.07 | $1,514 |
By year: 2022 $222K for 3,306 services; 2023 $167K for 2,332 services; 2024 $200K for 2,856 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brijesh Raval prescribed most often to Medicare patients was Daptomycin, with 134 prescriptions and refills. In total Brijesh Raval wrote 841 Medicare prescriptions that cost $275K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 134 | 134 | 34 | $111K |
| Meropenem Generic | 98 | 98 | 40 | $16K |
| Doxycycline Hyclate Generic | 86 | 90 | 66 | $1,452 |
| Cefepime Hcl Generic | 75 | 75 | 27 | $11K |
| Cefdinir Generic | 55 | 63 | 52 | $894 |
| Ceftriaxone Ceftriaxone Sodium | 50 | 50 | 21 | $3,009 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 40 | 40 | 17 | $7,836 |
| Micafungin Micafungin Sodium | 23 | 23 | Under 11 | $9,684 |
| Cefazolin Sodium Generic | 22 | 22 | Under 11 | $1,477 |
| Metronidazole Generic | 21 | 21 | 21 | $269 |
| Ceftazidime Generic | 21 | 21 | Under 11 | $1,813 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 21 | 16 | $61.16 |
| Amoxicillin Generic | 17 | 17 | 11 | $46.77 |
| Nafcillin Sodium Generic | 16 | 16 | Under 11 | $13K |
| Levofloxacin Generic | 15 | 15 | 15 | $93.59 |
Brand drugs: - claims; generic drugs: 796 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Brijesh Raval were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.